Patents by Inventor Philip Devlin

Philip Devlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240348059
    Abstract: Technologies for zero-emission power generation include a system with a power station unit coupled to multiple production units by an alternating current connection and a direct current connection. Each production unit may be a trailer for film and television production, an over-the-road trailer, or other portable unit. Each production unit includes a power generation system such as a photovoltaic solar power system. The power station unit causes power generated at the production units to flow to the power station unit via the direct current connections, and delivers the generated power to the production units via the alternating current connections. The generated power may be stored by the production units or used to power external loads or internal loads at the production units. Stored energy from the production units may flow to the power station unit via the direct current connections. Other embodiments are described and claimed.
    Type: Application
    Filed: March 25, 2024
    Publication date: October 17, 2024
    Inventors: Stephen Marc FREDERICK, Philip DEVLIN, Phillip Henry SLOANE
  • Publication number: 20060167370
    Abstract: The present invention is a system and method of deriving and computing features and indices that predict the likelihood of psychological and neurological adverse events such as suicidal thoughts and/or actions. The method of the present invention further predicts the likelihood of suicidal thoughts and/or actions prior to and or during treatment for psychological disease. To obtain such features and indices, power spectrum and time domain values are derived from biopotential signals acquired from the subject being tested. The system and method identify people who are likely to experience changing, especially worsening, symptoms of psychological and neurological adverse events such as suicidal thoughts or actions and who therefore may be at risk (e.g. suicide).
    Type: Application
    Filed: January 12, 2006
    Publication date: July 27, 2006
    Applicant: Aspect Medical Systems, Inc.
    Inventors: Scott Greenwald, Philip Devlin, Jeffrey Sigl
  • Publication number: 20060149160
    Abstract: The invention provides a method of estimating cerebral sources of electrical activity from a small subset of EEG channels utilizing existing methods to provide a 3-dimensional, discrete, distributed, linear solution to the inverse problem using inputs consisting of a small number of EEG channels (e.g., 4 channels) augmented with synthetic EEG data for the other channels. The resultant image of cerebral electrical activity in the region of the EEG channels from which data is recorded is of comparable spatial resolution in the corresponding region to images of cerebral electrical activity obtained using a complete set of EEG channels (e.g., using 24 channels).
    Type: Application
    Filed: December 5, 2005
    Publication date: July 6, 2006
    Applicant: Aspect Medical Systems, Inc.
    Inventors: Tim Kofol, Scott Greenwald, Philip Devlin
  • Publication number: 20050216071
    Abstract: Disclosed is a system and method of assessing the efficacy of and predicting response to treatment of neurological or psychological disorders. The preferred embodiment uses at least two surface electrodes to acquire EEG signals from the surface of a patient's body, a processor for computing from the EEG signals various features and indices that are representative of the patient's neurological or psychological state. Pretreatment indices represent a patient's neurological or psychological state and therefore may be used to predict the response to treatment. Changes in these parameters may be used to assess the efficacy of treatment and to modify the treatment to optimize the resultant patient state.
    Type: Application
    Filed: February 18, 2005
    Publication date: September 29, 2005
    Applicant: Aspect Medical Systems, Inc.
    Inventors: Philip Devlin, Scott Greenwald
  • Publication number: 20050043774
    Abstract: Disclosed is a system and method of assessing the efficacy of treatment of neurological or psychological disorders. The preferred embodiment uses at least two surface electrodes to acquire EEG signals from the surface of a patient's body, a processor for computing from the EEG signals various features and indices that are representative of the patient's neurological or psychological state. Changes in these parameters may be used to assess the efficacy of treatment and to modify the treatment to optimize the resultant patient state.
    Type: Application
    Filed: May 6, 2004
    Publication date: February 24, 2005
    Applicant: Aspect Medical Systems, Inc
    Inventors: Philip Devlin, Scott Greenwald